Drugdiscovery >> Drug Development >> News
5984
Views
title
Glucose-lowering drugs might have effects on heart - drugdiscovery.com


One of the most common reason of being hospitalized because opf heart failure is diabetes - according to the data. Scientist say, the hear-risk effect of glucose lowering drugs are often overlooked on clinical trials.
Read More >>


Tags: clinical trial, diabetes, gluvose-lowering drug, effect, heart, heart attack, heart failure - March 13, 2014
Related Articles
1068
Views
Side Effects free heart attack drug was unlocked Side Effects free heart attack drug was unlocked
Melbourne based scientists have taken a big step towards a drug, which can reduce the damage made by a heart attack significantly. The new discovery is unique since the drug does not have any of the w Read More >>

Tags: heart attack, heart attack damage, heart failure

1287
Views
Heart drug of novertis was rejected by FDA Heart drug of novertis was rejected by FDA
Cardiovascular and Renal Drugs Advisory Committee has rejected a new heart drug of Novartis. Serelaxin was not apporved due to lack of data. Read More >>

Tags: Serelaxin, heart failure, cardiovascular disease, novartis, FDA, FDA rejection

3525
Views
Huge ampunts of money invested to Flu-drugs uselessly Huge ampunts of money invested to Flu-drugs uselessly
According to a study millions of money is invested into drugs which are not better than the existing technologies, such as paracetamol. Taiflu might be one of them. Read More >>

Tags: Tamiflu, drugs, flu drugs, durg spending, price of drugs, money wasted on drugs.

4599
Views
Promising Compound Could Offer New Treatment for Heart Failure Promising Compound Could Offer New Treatment for Heart Failure
The discovery of a new molecular pathway responsible for causing heart failure lays the foundation for an entirely new way of treating a diseased heart by targeting cell nucleus. Read More >>

Tags: heart failure, new molecular pathway, JQ1

6677
Views
Novartis' Serelaxin is a breakthrough in heart drug development Novartis' Serelaxin is a breakthrough in heart drug development
Novartis have given breakthrough therapy status by FDA to an investigational treatment for patients with acute heart failure. Read More >>

Tags: heart failure,drug,Serelaxin

4402
Views
Carbohydrate-based drugs gaining more scientific attention Carbohydrate-based drugs gaining more scientific attention
Although carbohydrates have not received as much scientific attention in drug development as proteins or nucleic acids in the past, their complex chemistry might offer a broad range of new treatments Read More >>

Tags: Carbohydrate-based drugs, carbohydrates, drugs, drug development

4904
Views
Findings which could improve the development of new drugs for addiction Findings which could improve the development of new drugs for addiction
Scientists from the Scripps Research Institute recently published the results which could pave way to a more effective and safer drugs for addiction. Read More >>

Tags: drugs for addiction, 6’- guanidinonaltrindole , kappa opioid receptor, drug discovery

1494
Views
A step-forward in the field of paediatric drugs A step-forward in the field of paediatric drugs
Astra zeneca has made a step-forward in the field of paediatric drug-research. The cosnurtium of Molecular Profiles along with Pfizer, Bristol Myers Squibb, GlaxoSmithKline and academic institutions i Read More >>

Tags: Astra Zeneca, paediatric drugs, pharma

2589
Views
Novartis looks forward to have its new drug accepted in the EU Novartis looks forward to have its new drug accepted in the EU
Novartis has announced that it has submitted the revised service pack of Serelaxin to Committee for Medicinal Products for Human Use (CHMP). This drug is used in case of chronic heart failure. Read More >>

Tags: chronic heart failure, Committee for Medicinal Products for Human Use, Serelaxin

1297
Views
Xarelto as rejected by FDA Xarelto as rejected by FDA
Xarelto, the drug of Janssen was rejected by FDA. The edicine is used for treating secondary cardiovascular events - for instance heart attacks. Leaders of the research say, they remain committed to d Read More >>

Tags: Xarelto, coronary disease, drug, heart atack

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013